PL2200442T3 - Bakteriofag lub białko lityczne pochodzące z bakteriofaga, które są skuteczne do traktowania biofilmu staphylococcus aureus - Google Patents

Bakteriofag lub białko lityczne pochodzące z bakteriofaga, które są skuteczne do traktowania biofilmu staphylococcus aureus

Info

Publication number
PL2200442T3
PL2200442T3 PL08830287T PL08830287T PL2200442T3 PL 2200442 T3 PL2200442 T3 PL 2200442T3 PL 08830287 T PL08830287 T PL 08830287T PL 08830287 T PL08830287 T PL 08830287T PL 2200442 T3 PL2200442 T3 PL 2200442T3
Authority
PL
Poland
Prior art keywords
bacteriophage
effective
treatment
staphylococcus aureus
protein derived
Prior art date
Application number
PL08830287T
Other languages
English (en)
Inventor
Seongjun Yoon
Yunjaie Choi
Se Jung Lee
Jeesoo Son
Sooyoun Jun
Sanghyeon Kang
Original Assignee
Intron Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intron Biotechnology Inc filed Critical Intron Biotechnology Inc
Publication of PL2200442T3 publication Critical patent/PL2200442T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/40—Viruses, e.g. bacteriophages
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00031—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Biotechnology (AREA)
  • Agronomy & Crop Science (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
PL08830287T 2007-09-13 2008-09-12 Bakteriofag lub białko lityczne pochodzące z bakteriofaga, które są skuteczne do traktowania biofilmu staphylococcus aureus PL2200442T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020070092859A KR100910961B1 (ko) 2007-09-13 2007-09-13 황색포도상구균의 균막 처치에 효과적인 박테리오파지 또는그것 유래의 용균단백질
PCT/KR2008/005434 WO2009035303A2 (en) 2007-09-13 2008-09-12 Bacteriophage or lytic protein derived from the bacteriophage which effective for treatment of staphylococcus aureus biofilm
EP08830287.2A EP2200442B1 (en) 2007-09-13 2008-09-12 Bacteriophage or lytic protein derived from the bacteriophage which effective for treatment of staphylococcus aureus biofilm

Publications (1)

Publication Number Publication Date
PL2200442T3 true PL2200442T3 (pl) 2016-04-29

Family

ID=40452719

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08830287T PL2200442T3 (pl) 2007-09-13 2008-09-12 Bakteriofag lub białko lityczne pochodzące z bakteriofaga, które są skuteczne do traktowania biofilmu staphylococcus aureus

Country Status (12)

Country Link
US (1) US8377431B2 (pl)
EP (1) EP2200442B1 (pl)
KR (1) KR100910961B1 (pl)
CY (1) CY1118029T1 (pl)
DK (1) DK2200442T3 (pl)
ES (1) ES2560262T3 (pl)
HR (1) HRP20160038T8 (pl)
HU (1) HUE026532T2 (pl)
PL (1) PL2200442T3 (pl)
PT (1) PT2200442E (pl)
SI (1) SI2200442T1 (pl)
WO (1) WO2009035303A2 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100781669B1 (ko) 2006-06-20 2007-12-03 주식회사 인트론바이오테크놀로지 황색포도상구균 특이적 사멸능을 갖는 박테리오파지
KR100759988B1 (ko) * 2006-08-04 2007-09-19 주식회사 인트론바이오테크놀로지 황색포도상구균에 특이적인 항균 단백질
KR100910961B1 (ko) 2007-09-13 2009-08-05 주식회사 인트론바이오테크놀로지 황색포도상구균의 균막 처치에 효과적인 박테리오파지 또는그것 유래의 용균단백질
US8043613B2 (en) 2009-02-12 2011-10-25 Intron Biotechnology, Inc. Podoviriedae bacteriophage having killing activity specific to Staphylococcus aureus
US8377866B2 (en) 2009-02-12 2013-02-19 Intron Biotechnology, Inc. Antimicrobial protein derived from Podoviridae bacteriophage specific to Staphylococcus aureus
WO2013180316A1 (ko) * 2012-05-29 2013-12-05 주식회사 인트론바이오테크놀로지 박테리오파지 리신 단백질들의 안정성을 개선할 수 있는 조성물
KR101381795B1 (ko) 2013-02-27 2014-04-07 씨제이제일제당 (주) 신규 박테리오파지 및 이를 포함하는 항균 조성물
KR101381793B1 (ko) 2013-02-27 2014-04-07 씨제이제일제당 (주) 신규 박테리오파지 및 이를 포함하는 항균 조성물
KR101381797B1 (ko) 2013-02-27 2014-04-07 씨제이제일제당 (주) 신규 박테리오파지 및 이를 포함하는 항균 조성물
KR101381796B1 (ko) 2013-02-27 2014-04-25 씨제이제일제당 (주) 신규 박테리오파지 및 이를 포함하는 항균 조성물
KR101381798B1 (ko) 2013-02-27 2014-04-07 씨제이제일제당 (주) 신규 박테리오파지 및 이를 포함하는 항균 조성물
DE102013106455A1 (de) 2013-06-20 2014-12-24 Airbus Defence and Space GmbH Verfahren zur Dekontamination von bakteriologischen Verunreinigungen
KR20160032725A (ko) 2013-07-11 2016-03-24 마이크레오스 휴먼 헬스 비.브이. 아토피성 피부염에 대한 조합 치료
PL405911A1 (pl) 2013-11-04 2015-05-11 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością Białko o aktywności hydrolitycznej wobec polisacharydowych otoczek bakteryjnych, polinukleotyd kodujący to białko, biologicznie czynny wektor, kompozycja zawierająca białko i jego zastosowanie
US11252966B2 (en) * 2014-01-24 2022-02-22 The Procter & Gamble Company Fibrous structures comprising a surface care composition and methods for making and using same
US20170106058A1 (en) 2014-04-08 2017-04-20 Lysando Ag Pharmaceutical composition against chronic bacterial infections
KR101590108B1 (ko) 2014-04-10 2016-01-29 씨제이제일제당(주) 신규 박테리오파지 및 이를 포함하는 조성물
US9872893B2 (en) * 2014-07-10 2018-01-23 University Of Maryland College Park Endolysins active against Staphylococcus bacteria, pharmaceutical compositions, and methods relating thereto
KR101587113B1 (ko) * 2014-10-29 2016-01-20 경북대학교 산학협력단 치주염 유발 장알균(Enterococcus faecalis)을 특이적으로 사멸시키는 신규한 박테리오파지
RU2565824C1 (ru) * 2014-11-19 2015-10-20 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) ШТАММ БАКТЕРИОФАГА Staphylococcus aureus SA20, ОБЕСПЕЧИВАЮЩИЙ РАЗРУШЕНИЕ БИОПЛЕНОК, ОБРАЗУЕМЫХ БАКТЕРИЯМИ РОДА Staphylococcus
KR101643235B1 (ko) * 2015-06-03 2016-07-27 서울대학교산학협력단 황색포도상구균에 대해 숙주감수성을 나타내는 박테리오파지 시포비리데 패밀리 sap4 및 이를 함유하는 조성물
CN105132461B (zh) * 2015-09-10 2018-03-09 天津农学院 共表达SAL‑2和hLYZ双抑菌基因重组腺病毒的构建方法及重组腺病毒和应用
WO2017087909A1 (en) * 2015-11-19 2017-05-26 Epibiome, Inc. Bacteriophage compositions and methods of use thereof
US20170157186A1 (en) * 2015-12-02 2017-06-08 Smart Phage, Inc. Phage to treat bacteria on skin
AU2017208114B2 (en) * 2016-01-12 2023-04-13 Intron Biotechnology, Inc. An antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition
CN108463215A (zh) * 2016-01-12 2018-08-28 尹特荣生物科技株式会社 抗菌蛋白的冷冻干燥制剂
CN107779439B (zh) * 2016-08-24 2021-02-02 菲吉乐科(南京)生物科技有限公司 新的葡萄球菌噬菌体及其组合物、制备方法和应用
CN106636050A (zh) * 2017-01-17 2017-05-10 中国海洋大学 来源于耐甲氧西林金黄色葡萄球菌噬菌体的宽谱内溶素及其应用
EP4132552A2 (en) * 2020-04-06 2023-02-15 Adaptive Phage Therapeutics, Inc. Method for treating implantable device infections
KR102723118B1 (ko) * 2022-01-21 2024-10-28 서울여자대학교 산학협력단 스타필로코커스균 특이 박테리오파지 kmsp1 및 이를 포함하는 항균 조성물
KR102851110B1 (ko) * 2023-01-09 2025-08-27 가천대학교 산학협력단 신규한 스타필로코커스 우레일리티쿠스 박테리오파지 vB_SurP-PSU3 및 이의 용도
CN116410969B (zh) * 2023-04-24 2024-05-07 深圳北辰生物科技有限公司 一种噬菌体、噬菌体裂解酶及其用途
US12274722B1 (en) 2024-04-24 2025-04-15 Phage Technology Center Gmbh Antibiotic free treatment of mastitis

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU734420B2 (en) 1996-04-15 2001-06-14 Nymox Corporation Compositions containing bacteriophages and methods of using bacteriophages to treat infections
US6056954A (en) * 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US6264945B1 (en) * 1997-10-31 2001-07-24 Vincent A Fischetti Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
US6432444B1 (en) * 1997-10-31 2002-08-13 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymes for treating dermatological infections
US6056955A (en) * 1999-09-14 2000-05-02 Fischetti; Vincent Topical treatment of streptococcal infections
WO2002007742A2 (en) * 2000-07-25 2002-01-31 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Bacteriophage having multiple host range
CA2427928A1 (en) * 2000-11-02 2002-12-27 New Horizons Diagnostics Corporation The use of bacterial phage associated lytic enzymes to prevent food poisoning
ATE421249T1 (de) * 2002-02-13 2009-02-15 Immunology Lab Inc Zusammensetzungen und verfahren für die behandlung von mikroorganismen-infektionen
US20040081646A1 (en) 2002-08-29 2004-04-29 Engler Jeffrey A. Group B Streptococcal phage lysin
GB0300597D0 (en) 2003-01-10 2003-02-12 Microbiological Res Authority Phage biofilms
KR20060055461A (ko) 2003-08-21 2006-05-23 후지필름 일렉트로닉 머티리얼스 유.에스.에이., 아이엔씨. 신규한 감광성 이중층 조성물
CA2593992A1 (en) 2004-12-06 2006-06-15 Rodney M. Donlan Inhibition of biofilm formation using bacteriophage
KR100773888B1 (ko) 2006-02-16 2007-11-06 주식회사 지오제니컨설턴트 탄성파 탐사에서의 탄성파 발생시점을 검출하기 위한검출방법과 이를 이용한 탄성파 탐사 방법 및 장치
KR20070082358A (ko) 2006-02-16 2007-08-21 삼성전자주식회사 액정표시장치
KR20060073562A (ko) 2006-06-08 2006-06-28 김기철 이디피엠시트와 부틸고무를 압착하여 만든자착식합성고무시트
KR100781669B1 (ko) 2006-06-20 2007-12-03 주식회사 인트론바이오테크놀로지 황색포도상구균 특이적 사멸능을 갖는 박테리오파지
KR100759988B1 (ko) 2006-08-04 2007-09-19 주식회사 인트론바이오테크놀로지 황색포도상구균에 특이적인 항균 단백질
KR100910961B1 (ko) 2007-09-13 2009-08-05 주식회사 인트론바이오테크놀로지 황색포도상구균의 균막 처치에 효과적인 박테리오파지 또는그것 유래의 용균단백질
US8377866B2 (en) * 2009-02-12 2013-02-19 Intron Biotechnology, Inc. Antimicrobial protein derived from Podoviridae bacteriophage specific to Staphylococcus aureus
US8043613B2 (en) * 2009-02-12 2011-10-25 Intron Biotechnology, Inc. Podoviriedae bacteriophage having killing activity specific to Staphylococcus aureus

Also Published As

Publication number Publication date
HUE026532T2 (en) 2016-06-28
KR20090027783A (ko) 2009-03-18
HRP20160038T1 (hr) 2016-02-12
EP2200442A4 (en) 2012-09-12
KR100910961B1 (ko) 2009-08-05
EP2200442A2 (en) 2010-06-30
DK2200442T3 (en) 2016-02-01
WO2009035303A3 (en) 2009-05-14
EP2200442B1 (en) 2015-10-21
PT2200442E (pt) 2016-02-24
HRP20160038T8 (xx) 2016-03-11
CY1118029T1 (el) 2017-05-17
WO2009035303A2 (en) 2009-03-19
ES2560262T3 (es) 2016-02-18
US20100254950A1 (en) 2010-10-07
SI2200442T1 (sl) 2016-02-29
US8377431B2 (en) 2013-02-19

Similar Documents

Publication Publication Date Title
PT2200442E (pt) Bacteriófago ou proteína lítica derivada do bacteriófago eficaz no tratamento de biofilme formado por staphylococcus aureus
GB2480772B (en) Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus
IL213489A0 (en) Compositions and methods for the treatment of the prevention of e. coli infections and for the eradication or reduction of e. coli surfaces
GB0515550D0 (en) Inactivation of staphylococcus species
IL187999A0 (en) Compositions for the treatment of persistent infections
AP2010005480A0 (en) Small molecule inhibitors for the treatment or prevention of denque virus infection.
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
BRPI0812214A2 (pt) purificador desinfetante de efeito prolongado
BRPI0821810A2 (pt) Instalação de tratamento por imersão
BR112012010223A2 (pt) purificação de staphylococcus aureus tipo 5 e tipo 8 sacarídeos capsulares
ZA201005180B (en) Detection of methicillin-resistant staphylococcus aureus
ZA201006308B (en) Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
BRPI0816836A2 (pt) Composições de limpeza e/ou tratamento
BRPI0923567A2 (pt) agentes antibactericidas novos para o tratamento de infecções gram positivas
SG131822A1 (en) Treating avian influenza infections
EP2417258A4 (en) BACTERIOPHAGE COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS
DK2722053T3 (da) Antibakterielt middel til behandling af infektionssygdomme af bakteriel oprindelse
ZA201100468B (en) The treatment of helminthic infections
NL1033203A1 (nl) Verwerken of behandelen van gewas.
GB0817437D0 (en) Compounds for the treatment of flaviviral infections
GB0819518D0 (en) Compounds for the treatment of flaviviral infections
GB0814216D0 (en) Compounds for the treatment of flaviviral infections
GB0508324D0 (en) Antimicrobial treatment
GB0508328D0 (en) Antimicrobial treatment
GB0508303D0 (en) Antimicrobial treatment